Christopher Logan , FNP-C
Nurse Practitioner - Primary Care • San Antonio, TX
11345 Alamo Ranch Pkwy Ste 103
San Antonio, TX 782536442
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
Christopher Logan is listed in NPPES under Nurse Practitioner - Primary Care.
-
NPI assigned on October 6, 2019; this date does not establish years in practice.
-
Published CMS data list 1,113 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Telmisartan — 62 prescription fills, including refills.
- Ezetimibe — 62 prescription fills, including refills.
- Levothyroxine Sodium — 56 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 49 records in the table · Guide: How to read Medicare Part D prescriber data
-
More Part D prescriptions than 65% of clinicians listed under Nurse Practitioner - Primary Care in San Antonio, TX (2024, 22 clinicians with data). Median for this group: 546. Middle half: 143 to 1,604.
More Part D prescriptions than 65% of clinicians listed under Nurse Practitioner - Primary Care in Texas (2024, 303 clinicians with data). Median for this group: 552. Middle half: 142 to 1,481.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part D prescriptions went from 58 in 2020 to 1,113 in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2020–2024.
Practice Location & Contact Primary Location
11345 Alamo Ranch Pkwy Ste 103
San Antonio, TX 782536442
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
What Public CMS Data Show
Nurse Practitioner - Primary Care: NPPES taxonomy is a reported classification, not proof of board certification.
30-day fills
2,584 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$173,063 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $2,273.73 across 113 records.
By nature of payment
- Food and Beverage: $2,273.73 across 113 records.
Reporting-company totals (3 largest of 18)
- ABBVIE INC.: $424.50 across 30 records.
- Novo Nordisk Inc: $285.67 across 14 records.
- Bayer Healthcare Pharmaceuticals Inc.: $284.62 across 11 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
NPI first issued
2019
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Medicare assignment not listed
CMS data do not show whether this clinician accepts Medicare assignment. This does not mean they do not accept Medicare. Ask the office.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Compared with the same specialty in San Antonio and Texas
Billing and prescribing volume is not a quality rating.
Medicare Part D prescriptions
More Part D prescriptions than 65% of clinicians listed under Nurse Practitioner - Primary Care in San Antonio, TX (2024, 22 clinicians with data). Median for this group: 546. Middle half: 143 to 1,604.
More Part D prescriptions than 65% of clinicians listed under Nurse Practitioner - Primary Care in Texas (2024, 303 clinicians with data). Median for this group: 552. Middle half: 142 to 1,481.
Part D drug cost
A higher Part D drug cost than 60% of clinicians listed under Nurse Practitioner - Primary Care in San Antonio, TX (2024, 22 clinicians with data). Median for this group: $30,829. Middle half: $1,182 to $214,797.
A higher Part D drug cost than 75% of clinicians listed under Nurse Practitioner - Primary Care in Texas (2024, 303 clinicians with data). Median for this group: $40,304. Middle half: $2,642 to $146,601.
46 active clinicians are listed under Nurse Practitioner - Primary Care with a practice address in San Antonio, TX (824 in Texas).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in San Antonio
15.2% of these 46 clinicians have the CMS telehealth indicator.
41.3% of these 46 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part D prescriptions
Medicare Part D prescriptions increased 1819% from 58 in 2020 to 1,113 in 2024.
- 2020: 58
- 2021: 483
- 2022: 794
- 2023: 1,004
- 2024: 1,113
-
30-day fills
30-day fills increased 2484% from 100 in 2020 to 2,584 in 2024.
- 2020: 100
- 2021: 877
- 2022: 1,694
- 2023: 2,169
- 2024: 2,584
-
Part D drug cost
Part D drug cost went from $834 in 2020 to $173,063 in 2024.
- 2020: $834
- 2021: $17,911
- 2022: $29,919
- 2023: $69,596
- 2024: $173,063
-
Industry payments (Open Payments)
Industry payments (Open Payments) increased 89% from $1,200.86 in 2021 to $2,273.73 in 2025.
- 2021: $1,200.86
- 2022: $1,307.81
- 2023: $1,954.18
- 2024: $1,754.72
- 2025: $2,273.73
Sources: CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 113 records totaling $2,273.73.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Axsome Therapeutics, Inc. |
Food and Beverage
In-kind items and services
|
Auvelity | General | $124.99 |
| Otsuka America Pharmaceutical, Inc. |
Food and Beverage
In-kind items and services
|
REXULTI | General | $121.86 |
| Bayer Healthcare Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
Kerendia | General | $118.94 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
FARXIGA | General | $106.71 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
VRAYLAR | General | $34.94 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) |
Food and Beverage
In-kind items and services
|
CAPLYTA | General | $33.90 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
UBRELVY | General | $30.67 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
QULIPTA | General | $30.67 |
| SHIELD THERAPEUTICS INC |
Food and Beverage
In-kind items and services
|
ACCRUFER | General | $30.22 |
| Eli Lilly and Company |
Food and Beverage
In-kind items and services
|
MOUNJARO | General | $27.45 |
| Bayer Healthcare Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
Kerendia | General | $27.19 |
| Novo Nordisk Inc |
Food and Beverage
In-kind items and services
|
— | General | $27.00 |
| GlaxoSmithKline, LLC. |
Food and Beverage
In-kind items and services
|
TRELEGY ELLIPTA | General | $26.07 |
| Corcept Therapeutics |
Food and Beverage
In-kind items and services
|
Korlym | General | $25.11 |
| Pfizer Inc. |
Food and Beverage
In-kind items and services
|
NURTEC ODT | General | $23.86 |
| Amgen Inc. |
Food and Beverage
In-kind items and services
|
REPATHA | General | $23.40 |
| Bayer Healthcare Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
Kerendia | General | $23.36 |
| Novo Nordisk Inc |
Food and Beverage
In-kind items and services
|
— | General | $22.94 |
| Novo Nordisk Inc |
Food and Beverage
In-kind items and services
|
Wegovy | General | $22.80 |
| SHIELD THERAPEUTICS INC |
Food and Beverage
In-kind items and services
|
ACCRUFER | General | $22.48 |
| Eli Lilly and Company |
Food and Beverage
In-kind items and services
|
ZEPBOUND | General | $22.17 |
| Novo Nordisk Inc |
Food and Beverage
In-kind items and services
|
— | General | $22.07 |
| Novo Nordisk Inc |
Food and Beverage
In-kind items and services
|
Wegovy | General | $22.02 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
AIRSUPRA | General | $21.65 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
VRAYLAR | General | $21.54 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Telmisartan | Telmisartan | 62 | 5,490 | $1,056.86 | 25 |
| Ezetimibe | Ezetimibe | 62 | 5,220 | $2,074.96 | 26 |
| Levothyroxine Sodium | Levothyroxine Sodium | 56 | 4,920 | $487.65 | 26 |
| Liothyronine Sodium | Liothyronine Sodium | 51 | 4,011 | $2,296.92 | 16 |
| Amlodipine Besylate | Amlodipine Besylate | 48 | 4,020 | $87.81 | 20 |
| Ozempic | Semaglutide | 39 | 1,708 | $52,081.78 | — |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 38 | 3,000 | $512.19 | 13 |
| Atorvastatin Calcium | Atorvastatin Calcium | 35 | 3,120 | $340.29 | 15 |
| Alprazolam | Alprazolam | 34 | 1,020 | $189.23 | — |
| Lisinopril | Lisinopril | 32 | 2,820 | $221.02 | — |
| Losartan Potassium | Losartan Potassium | 29 | 2,500 | $142.27 | — |
| Pioglitazone Hcl | Pioglitazone Hcl | 24 | 2,160 | $289.62 | 11 |
| Np Thyroid | Thyroid,pork | 23 | 1,710 | $2,028.49 | — |
| Farxiga | Dapagliflozin Propanediol | 23 | 1,590 | $28,720.62 | — |
| Progesterone | Progesterone, Micronized | 23 | 1,140 | $347.05 | — |
| Clonazepam | Clonazepam | 22 | 560 | $19.42 | — |
| Allopurinol | Allopurinol | 21 | 1,850 | $252.79 | 12 |
| Escitalopram Oxalate | Escitalopram Oxalate | 21 | 1,230 | $144.55 | — |
| Jardiance | Empagliflozin | 21 | 1,710 | $32,024.87 | — |
| Kerendia | Finerenone | 21 | 1,380 | $28,452.16 | — |
| Fluticasone Propionate | Fluticasone Propionate | 20 | 1,170 | $154.37 | 11 |
| Lorazepam | Lorazepam | 20 | 510 | $5.86 | — |
| Quetiapine Fumarate | Quetiapine Fumarate | 20 | 1,350 | $338.02 | — |
| Ezetimibe-Simvastatin | Ezetimibe/Simvastatin | 20 | 1,350 | $445.18 | — |
| Meloxicam | Meloxicam | 18 | 600 | $49.01 | — |
(top 25 shown)
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
NUCC Taxonomy Code: 363LP2300X
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Nurse Practitioner
Advanced Practice Registered Nurse - Certified Nurse Practitioner
Nurse Practitioner - Family
NURSEPRACTITIONER
Nurse Practitioner - Family
Nurse Practitioner (Certified)
Career & Practice History
NPI enumerated October 06, 2019.
No changes to the name, practice address, taxonomy or NPI status in this record have been observed in the monthly NPPES data files from October 2019 to August 2026.
NPI Administrative Meta
Other Nurse Practitioner - Primary Care Specialists in San Antonio
- Gilbert Cervantes, FNP-C
- Jennifer Montalvo, APRN FNP
- Eileen Donnelly, FNP-C
- Bernadette Kucinski, NP
- Martha Ruiz, AGNP
- Gabriella Mutschlechner, FNP-C
Mailing Address
10210 Windstone Crk
San Antonio, TX 782546032
Phone: 2103797195